Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in"herbal high" products

Journal of Analytical Toxicology

Volumn 34, Issue 5, 2010, Pages 252-260

  Hudson, Simon ^a   Ramsey, John ^b   King, Les ^c   Timbers, Sarah ^a   Maynard, Steve ^a   Dargan, Paul I ^d   Wood, David M ^d  

^a LGC   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c Home Office Advisory Council on the Misuse of Drugs   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 3 [2 HYDROXY 4 (1,1 DIMETHYLHEPTYL)PHENYL]CYCLOHEXANOL; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CP47,497; HERBACEOUS AGENT; INDOLE DERIVATIVE; JWH 007; JWH 019; JWH 047; JWH 049; JWH 073; JWH 081; JWH 122; JWH 180; JWH 182; JWH 213; JWH 398; PHENOL DERIVATIVE; UNCLASSIFIED DRUG; CANNABINOID RECEPTOR;

ACCURACY; ARTICLE; DRUG ANALYSIS; DRUG CONTROL; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SCREENING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SPICE; TANDEM MASS SPECTROMETRY; CHEMISTRY; DRUG POTENTIATION; HIGH THROUGHPUT SCREENING; HUMAN; METHODOLOGY; SUBSTANCE ABUSE;

CANNABINOIDS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; RECEPTORS, CANNABINOID; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 77955897603     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.5.252     Document Type: Article

References (18)

1. V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz, N. Ferreirós. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 44: 832-837 (2009).
2. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara,Y. Haishima, and Y. Goda. Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull. 57: 439- 441 (2009).
3. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara, and Y. Goda. Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol. 27: 61-66 (2009).
4. R. Lindigkeit, A. Boehme, I. Eiserloh, M. Luebbecke, M Wiggermann, L. Ernst, and T. Beuerle. Spice: a never ending story? Forensic Sci. Int. 191: 58-63 (2009).
5. R. Sedefov, A. Gallegos, L. King, D. Lopez,V. Auwärter, B. Hughes, and P. Griffiths. Understanding the 'Spice' phenomenon. EMCDDA Thematic paper, 2009.
6. DEA (U.S. Drug Enforcement Administration). Microgram Bull. 42: 23-24 (2009).
7. U.S. Zimmermann, P.R. Winkelmann, M. Pilhatsch, J.A. Nees, R. Spanagel, and K. Schulz. Withdrawal phenomena and dependence syndrome after the consumption of "Spice Gold". Dtsch Arztebl Int. 106: 464-467 (2009).
8. Advisory Council on the Misuse of Drugs, Consideration of the major cannabinoid agonists. Home Office, London, 2009. http://drugs.homeoffice.gov.uk/publication-search/acmd/acmdreport-agonists?view=Binary.
9. 1 cannabinoid receptor. Bioorg. Med. Chem. 11: 539-549 (2003).
10. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54: 161-202 (2002).
11. 2 receptor binding. Drug Alcohol Depend. 60: 133-140 (2000).
12. 2 receptor agonists. Bioorg. Med. Chem. 13: 89-112 (2005).
13. J.L. Wiley, D.R. Compton, D. Dai, J.A. Lainton, M. Phillips, J.W. Huffman, and B.R. Martin. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J. Pharmacol. Exp. Ther. 285: 995-1004 (1998).
14. J.W. Huffman. Cannabimimetic indoles, pyrroles, and indenes: structure-activity relationships and receptor interactions. In The Cannabinoid Receptors, P.H. Reggio, Ed. Humana Press, Totowa, NJ, 2009, pp 49-94.
15. R.G. Pertwee. Pharmacological actions of cannabinoids. In Cannabinoids, R. Pertwee, Ed. Springer Press, New York, NY, 2005, pp 1-51.
16. 8-THC isomers; exceptionally potent cannabinoids. Bioorg. Med. Chem. Lett. 7: 2799-2804 (1997).
17. D.R. Compton, M.R. Johnson, L.S. Melvin, and B.R. Martin. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 260: 201-209 (1992).
18. D.R. Compton, K.C. Rice, B.R. De Costa, R.K. Razdan, L.S. Melvin, M.R. Johnson, and B.R. Martin. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265: 218-226 (1993).